The classical theory of enzymatic inhibition aims to quantitatively describe the effect of certain molecules-called inhibitors-on the progression of enzymatic reactions, but "nonclassical effects" and "anomalies" which seem to fall beyond its scope have forced practitioners and others to repeatedly patch and mend it ad-hoc. For example, depending on concentrations, some molecules can either inhibit, or facilitate, the progression of an enzymatic reaction. This duality gives rise to non-monotonic dose response curves which seriously complicate high throughput inhibitor screens and drug development, but it is widely believed that the three canonical modes of inhibition-competitive, uncompetitive, and mixed-cannot account for it. To critically test this view, we take the single enzyme perspective and rebuild the theory of enzymatic inhibition from the bottom up. We find that accounting for multi-conformational enzyme structure and intrinsic randomness cannot undermine the validity of classical results in the case of competitive inhibition; but that it should strongly change our view on the uncompetitive and mixed modes of inhibition. In particular, we show that inhibitor-activator duality is inherent to these modes of "inhibition", and state-in terms of experimentally measurable quantities-a condition assuring its emergence. Fundamental and practical implications of our findings are discussed.
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Enzymes spin the wheel of life by catalyzing a myriad of chemical reactions central to the growth, development, and metabolism of all living organisms 1, 2 . Without enzymes, essential processes would progress so slowly that life would virtually grind to a halt; and some enzymatic reactions are so critical that inhibiting them may even result in immediate death. Enzymatic inhibitors could thus be potent poisons 3, 4 but could also be used as antibiotics 5, 6 and as drugs to treat other forms of disease 7, 8 . Inhibitors have additional commercial uses 9, 10 , but the fundamental principles which govern their interaction with enzymes are not always understood in full, and have yet ceased to fascinate those interested in the basic aspects of enzyme science. The canonical description of enzymatic inhibition received much exposure and can be found in various texts 1, 2, 11 . Its limitations are, however, much less appreciated, and while serious attempts to draw attention to this fact and tackle some of the inherent difficulties have been made 12 , they have so far been limited by the same bulk based approach that crippled the classical theory from its very inception.
Single molecule approaches have revolutionized our understanding of enzymatic catalysis 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33 , but similar studies of enzymatic inhibition trail behind and are just starting to emerge 34, 35, 36, 37, 38 . Given the revolutionary potential of these studies it is somewhat surprising that our understanding of enzymatic inhibition is still based, by and large, on experiments made in the bulk and on a theory, that is now many decades old. Rebuilding the theory of enzymatic inhibition from the bottom up thus looks appealing but is easier said than done. Stochastic, single-molecule, descriptions of inhibited enzymatic catalysis exist, but these are oftentimes based on simple kinetic schemes that fail to capture the multi-conformational nature of enzymes, or properly account for (1) fsg intrinsic randomness at the microscopic level. From a mathematical perspective, these kinetic schemes are usually built as Markov chains, and while expanding those to account for additional complexity is-in principle-always possible, this then necessitates the introduction of a large number of parameters. These, not only complicate the analysis, but also make it extremely difficult to identify universal results and principles which are key ingredients of any successful theory. Here, we circumvent these problems by adopting a generic, not necessarily Markovian, description of enzymatic catalysis. This approach has recently allowed us to dispense many of the restrictive assumptions that are usually made to shed new light on the role of unbinding in uninhibited enzymatic reactions 39 ; and have furthermore opened the door for fundamental advancements to be made in the theory of first passage time processes 40, 41, 42 . Below, we extend this approach to treat inhibited enzymatic reactions and show that this has far reaching implications on conventional wisdom in this field.
The classical theory of enzymatic inhibition considers the effect of molecular inhibitors on enzymatic reactions in the bulk, and focuses on three canonical modes of inhibition (Fig. 1) . In this theory, the concentrations of enzyme, substrate, inhibitor, and the various complexes formed are taken to be continuous quantities and differential equations are written to describe their evolution in time. Assuming that inhibitor molecules can bind either to the free enzyme, E, or the enzyme substrate complex, , as in the case of mixed inhibition (Fig. 1) , and that all complexes reach fast equilibrium (the quasisteady-state approximation), it can be shown that the per enzyme turnover rate, , of an inhibited enzymatic reaction obeys
.
Here, [ ] and [ ] respectively denote the concentrations of substrate and inhibitor, is the maximal, per enzyme, turnover rate attained at an excess of substrate and no inhibition, is the so-called Michaelis constant-the substrate concentration required for the rate of the uninhibited reaction to reach half its maximal value, and and denote the equilibrium constants related with reversible association of the inhibitor to form the molecular complexes and , respectively. The constants, , and could then be expressed through the rates of the elementary processes in Fig. 1 The kinetic schemes described in Fig. 1 also serve as a starting point for a single-molecule theory of enzymatic inhibition. This theory is fundamentally different from the bulk one as it should describe the stochastic act of a single enzyme embedded in a "sea" of substrate, and inhibitor, molecules. However, the main observable here is once again the turnover rate, , which is defined as the mean number of product molecules generated by a single enzyme per unit time. Equivalently, this rate can also be defined as the inverse of the average turnover time, 〈 〉, defined as the mean time between successive product formation events. Adopting 〈 〉 ≡ 1/ as a convention, the rate based description in Fig.1 can be interpreted as a Markovian scheme which governs the state-tostate transitions of a single enzyme, and it can once again be shown that Eq. (1) 
holds (SI).
Beyond the Classical Theory. The kinetic schemes presented in Fig. (1) do not account for additional enzymatic states that are often part of the reaction, and it is a priori unclear how these could affect the validity of the result in Eq. (1). For example, it is often necessary to discriminate between distinct enzyme-substrate complexes, but this could be done in a multitude of ways ( Fig. 2 left) , and the effect of inhibition should then be worked out on a case-by-case basis. This could work well when relevant states and transition rates can be determined experimentally, but doing so is often not possible technically or simply too laborious. Indeed, in the overwhelming majority of cases the number of intermediates and the manner in which they interconvert is simply unknown, resulting in a dire need for a description that will allow these to be effectively taken into account when information is missing or unspecified. Such description would also be useful when trying to generalize lessons learned from the analysis of simple case studies of enzymatic inhibition.
Generic reaction schemes could be built by retaining the same state space as in the classical approach ( Fig. 1 ) while replacing the all so familiar transition rates with generally distributed transition times. This is done in order to account for the coarse grained nature of states, and allows for an equivalent, but much more concise, description of complex reaction schemes. The time for the completion of a transition between two states is then characterized by a generic probability density function (PDF), e.g., ( ) in the case of the catalysis time,
, which governs the transition between the ES and E+P states above (Fig. 2  right) . Applied to all other transitions, an infinitely large collection of reactions schemes could then be analyzed collectively, potentially revealing striking universalities that have so far managed to remain hidden.
Competitive Inhibition at the Single-Enzyme
Level. To concretely exemplify the approach proposed above we consider a generic, not necessarily Markovian, scheme for competitive inhibition at the single-enzyme level (Fig. 3 ). As When all intermediates and rates are known, these complications could, in principle, be addressed on a case by case basis. Alternatively, one could account for the non-Markovian nature of transitions between coarse grained states by allowing for generally, rather than exponentially, distributed transition times. The main advantage of this approach is that it allows for progress to be made even when the underlying reaction schemes are not known in full, i.e., in the absence of perfect information. fsg usual in this mode of inhibition, the inhibitor can bind reversibly to the enzyme to form an enzyme-inhibitor complex which in turn prevents substrate binding and product formation. However, and in contrast to the Markovian approach, here we do not assume that the catalysis time is taken from an exponential distribution with rate , but rather let this time come from an arbitrary distribution. Since the enzyme is single but the substrate and inhibitor are present in Avogadro numbers, we assume that the binding times and are taken from exponential distributions with rates [ ] and [ ] correspondingly, but the distributions of the off times and are once again left unspecified. We then find that the turnover rate of a single enzyme obeys (SI)
Note that despite the fact that it is much more general, Eq. (2) shows the exact same dependencies on the substrate and inhibitor concentrations as in the classical theory (Eq. (1) in the limit ESI → ∞). This result is non-trivial, and turns out to hold irrespective of the mechanisms which govern the processes of catalysis and unbinding. However, and in contrast to Eq. (1), the constants , and , which enter Eq. (2), can no longer be expressed in terms of simple rates, and are rather given by (SI): (Fig. 4 top) where the multi-conformational nature of enzymes may lead to strong deviations from the classical behavior. To see this, we follow a similar path to that taken above and obtain a generalized equation for the turnover rate of a single enzyme in the presence of uncompetitive inhibitors (SI)
, where = (⟨ ⟩ ) −1 . Equation (3) should be compared to Eq. (1) in the limit EI → ∞, and we once again see that both exhibit the same characteristic 1/[S] dependence. Dependence on inhibitor concentration is, however, different from that in Eq. (1) this is no longer true and the classical theory simply breaks down.
To start and understand the reasons for this breakdown, and demonstrate the type of novel phenomena that may resultantly emerge, we consider-for illustration purposes-a model which is a simple generalization of the classical kinetic scheme for uncompetitive inhibition. Namely, we take ( ) = (1) exp(− (1) ) + (1 − ) (2) exp(− (2) ) with 0 ≤ ≤ 1, for the PDF of the catalysis time in Fig. 4 (top) , and keep all other transitions times exponential. When written down explicitly (Fig. 4 bottom) (Fig. 5b) , and is thus a measurable telltale sign of nonMarkovian kinetics.
Another important ramification is illustrated in Fig. 5C , where we plot the turnover rate from Eq. (3) respectively, and the PDF of the catalysis time as specified in the main text, the top and bottom schemes can be shown equivalent (SI). (Fig. 4 bottom) Binding an inhibitor prevents the formation of a product, but in the two state model it could also act as an effective switch between fast and slow catalytic states. If one state is characterized by a catalytic rate that is much higher than that of the other (
Uncompetitive Inhibition ( ) ( )

Two-state toy model
(1) ≫ (2) ), the time scale separation allows for inhibitor binding to be just as frequent so as to quickly terminate the slow catalytic pathway, but just as infrequent (hence the need for relatively low inhibitor concentrations) so as not to interrupt catalysis when it occurs rapidly enough (often through the fast pathway). When an inhibitor molecule binds it is then usually to the "slow state" ( 2 above), but when it unbinds there is some chance that the system instead returns to the "fast state" ( 1 above). If the ESI complex is (Fig. 4 bottom) . Here, activation is the phase where turnover is higher than its value in the absence of inhibition (i.e., when [I]=0), and any increase in inhibitor concentration increases turnover further; transition is the phase where turnover is still higher than its value in the absence of inhibition, but where further increase in inhibitor concentration results in a decrease of the turnover rate; and inhibition is the phase where turnover is lower than its value in the absence of inhibition, and any increase in inhibitor concentration decreases turnover further still. Keeping substrate concentration fixed, and varying the concentration of the inhibitor, turnover attains a maximum when crossing the line which separates the activation and transition phases, and reattains its value at [I]=0 when crossing the line which separates the transition and inhibition phases. Plots were made for three, qualitatively distinct, phases. As before, we observe that as inhibitor concentrations increase an activator-inhibitor transition may take place, but it can now also be seen that the manner in which this transition unfolds depends on the concentration of the substrate (Fig. 6A) , and that in some cases a transition only occurs when this concentration is low enough (Figs. 6B  & 6C) , or not at all (see discussion above). The challenge is then to provide a general condition asserting the onset of inhibitor-activator duality in enzymatic catalysis.
Enzymatic reactions may involve a large number of intermediate states and reaction pathways and could thus be markedly more complex than the two-state model considered above. However, rather than analyzing additional case studies one at a time, the approach developed herein allows us to treat an infinite collection of reaction schemes in a joint (4) fsg and unified manner, and without making any additional assumptions. Analyzing the generic reaction scheme for uncompetitive inhibition (Fig. 4 top) we find (SI) that a condition asserting the emergence of inhibitor-activator duality (i.e., asserting that / [ ]| [ ]=0 > 0), can be written in terms of experimentally measurable quantities as
Here, ⟨ ⟩, on the left hand side, is the mean life time of the ESI complex, but all other terms which enter Eq. (4) is large enough the inequality in Eq. (4) will most certainly hold and the emergence of an activator-inhibitor transition is guaranteed. The second term in Eq. (4) accounts for a possible bias in the breakdown of the ES complex in the absence of inhibition. Here, ⟨ 0 | → + ⟩ stands for the mean life time of this complex given that its breakdown resulted in product formation. This mean conditional lifetime could be shorter, or longer, than the (unconditional) mean lifetime ⟨ 0 ⟩ and we see that when it is shorter, i.e., when a product formation event also implies a shorter lifetime on average, the contribution coming from this term is positive. Low enough substrate concentrations will then assert the emergence of an activator-inhibitor transition, and an expression for the exact critical concentration at which this happens can be readily attained by rearrangement. A probabilistic derivation of Eq. (4) and thorough explanation of the intuition and rational behind it are given in the methods section.
Conclusions & Outlook.
How would the average rate at which an enzyme converts substrate into product change in the presence of a molecule whose binding to the enzyme completely shuts down its ability to catalyze? As we have shown, the answer to this question is not as simple and straightforward as it seems and curiously depends on the mode of inhibition, the molecular inner workings of the enzyme, and is further subject to a delicate interplay between substrate and inhibitor concentrations. The classical theory of inhibition provides no clue to this, but the single-enzyme approach taken herein shows that a molecule whose binding prevents enzymatic activity will act as an inhibitor when in high concentrations, but may change its skin and act as an activator when its abundance is low. This finding not only exposes fundamental flaws in our current understanding of enzymatic inhibition, but also has direct practical implications as inhibitors are in widespread commercial use.
To illustrate this, we take for example the case of DAPT, a compound tested and verified to act as an inhibitor of γ-secretase. Developed and researched for over a decade, this once promising treatment of Alzheimer's disease was eventually abandoned when it was discovered that when administered at low concentrations,
and when substrate concentrations were also low, it acted as an activator 43, 44, 45, 46 . More awareness to this issue would have surely resulted in earlier discovery of the biphasic response, saving precious time and money, but our findings suggest that this may be the tip of the iceberg. Inhibitor-activator duality is inherent to the uncompetitive mode of inhibition, and while it has so far been explained using specially tailored reactions schemes, we have shown that these are not needed. Moreover, the emergence of the effect could be predicted based on the stochastic kinetics of the enzyme in the absence of inhibition, and Eq. (4) further implies that the effect may even be observed in enzymes exhibiting multiconformational (non-Markovian) kinetics from the kind that has already been documented in the past 15, 16, 17 .
Concluding, we note that the mixed mode of inhibition is subject to the same type of analysis applied above. In this case we find (SI)
, and an equation analogous to Eq. (4) could also be obtained (SI). In fact, all of the results in this paper could be derived starting from Eq. (5), which generalizes Eq. (1) and should moreover replace it in future discussions of enzymatic inhibition. Specifically, note that the structure of Eq. (5), and that of Eqs. (2) & (3) as special cases, casts doubt on the ability of classical methods, e.g., that of Lineweaver & Burk 47 , to reliably discriminate between different modes of enzymatic inhibition, and suggests that these should also be revised. Finally, we note that while the framework considered herein allows for arbitrary, rather than exponentially, distributed transition times between kinetic states, it still retains the common assumption (also used in the stochastic derivation of Eq. (1)) that the system "forgets" the state of origin after leaving it 48 . Accounting for memory of past states could be important in certain cases, but the incorporation of a general form of such memory into the framework presented herein currently seems out of reach. Progress in this direction is an important future challenge and is anticipated to advance both theory and practice. Here, and are defined as they were right after Eq. 
Methods
II. Probabilistic derivation of Eq. (4).
When will the introduction of an uncompetitive inhibitor increase the turnover rate? Consider the difference between a scenario where inhibitor molecules are not present, and a (M5) fsg scenario where they are present at exceedingly low concentrations. Any interaction between the ES complex and an inhibitor molecule would then be very rare but will eventually happen, at some point in time, and we would like to determine the effect this has on the average time it takes the reaction cycle to complete.
After the inhibitor binds, an ESI complex is formed. It then takes the inhibitor ⟨ ⟩ units of time, on average, to unbind, and for the enzyme another 〈 0 〉 − 〈 〉 units of time to form a product after having just returned to the ES state. Here, the mean turnover time in the absence of inhibition,
1 , was used since inhibitor concentrations were assumed to be exceedingly low. This allows us to safely neglect the probability the enzyme encounters an inhibitor again within the remaining span of the turnover cycle, and one then only needs to note that the mean substrate binding time 〈 〉 was subtracted from 〈 0 〉 because the reaction continues from the ES state rather than starts completely anew. In total, a product will then be formed after ⟨ Suppose now that instead of having the inhibitor bind the ES complex as described above, the reaction would have simply carried on uninterruptedly from that point onward, i.e., as it would in the absence of inhibition. How much time would it then take it to complete? To answer this, we observe that the inhibitor encountered the ES complex at a random point in time, as opposed to immediately after its formation. Having already spent some amount of time at the ES state, the mean time remaining before the system exits this state need not necessarily be identical to the mean life time, ⟨ 0 ⟩, of a freshly formed ES complex in the absence of inhibition. Indeed, the time we require here is the mean residual life time of the ES complex, i.e., starting from the random point in time at which it encountered the inhibitor and onward. A key result in renewal theory then asserts that, when averaged over all possible encounter times, the mean residual life time is given by After the system exits the ES state two things could happen. If a product is formed the reaction there ends. Otherwise, the enzyme reverts back to its free state, and the reaction takes, on average, another 〈 0 〉 units of time to complete. When the enzyme first enters the ES state the probability that a product is formed is Pr( < ). What is, however, the probability that a product is formed from an ES complex that is first observed at some random point in time as in the scenario described above? Looking at the total time an enzyme spends at the ES state across many turnover cycles, this probability should coincide with the relative time fraction taken by ES visits which end in product formation, and this is given by (4) is given in the SI.
